City
Epaper

Russia logs 13,447 new Covid cases

By IANS | Updated: February 18, 2021 17:10 IST

Moscow, Feb 18 Russia registered 13,447 more Covid-19 cases over the past 24 hours, up from 12,828 a ...

Open in App

Moscow, Feb 18 Russia registered 13,447 more Covid-19 cases over the past 24 hours, up from 12,828 a day earlier, the country's Covid-19 response centre said on Thursday.

The national tally has thus increased to 4,125,598 with 81,926 deaths and 3,661,312 recoveries, the Xinhua news agency reported.

Moscow, Russia's worst-hit region, reported 1,950 new cases, taking the city's total to 962,637.

Moscow Mayor Sergei Sobyanin said on Thursday that around 600,000 residents in the city have received the jab as the vaccination roll-out continues.

More than 107.9 million Covid-19 tests have been conducted across Russia.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Sergey SobyaninRussiaXinhuaMoscow
Open in App

Related Stories

InternationalTurkish Oil Tanker MT Altura Carrying One Million Barrels of Russian Crude Hit by Drone in Black Sea Near Istanbul

InternationalRussia Blocks WhatsApp: Meta-Owned Company Says Country Trying to Isolate Over 100 Million Users

InternationalStabbing Attack at Russian University: Four Indian Students Injured in Knife Attack at Ufa Hostel

InternationalMoscow: One Killed, 3 Injured in Knife Attack at School in Odintsovo

InternationalRussia Market Fire: One Dead, Two Injured as Massive Blaze Sweeps Through St Petersburg Complex (Watch Video)

Health Realted Stories

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns